标题
Next-generation influenza vaccines: opportunities and challenges
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-02-15
DOI
10.1038/s41573-019-0056-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Immunity to Influenza: Catching a Moving Target To Improve Vaccine Design
- (2019) Catharine I. Paules et al. JOURNAL OF IMMUNOLOGY
- With a Little Help from T Follicular Helper Friends: Humoral Immunity to Influenza Vaccination
- (2019) Marios Koutsakos et al. JOURNAL OF IMMUNOLOGY
- Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages
- (2019) Kizzmekia S. Corbett et al. mBio
- Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
- (2019) Masaru Kanekiyo et al. NATURE IMMUNOLOGY
- Neuraminidase, the forgotten surface antigen, emerges as an influenza vaccine target for broadened protection
- (2019) Maryna C Eichelberger et al. JOURNAL OF INFECTIOUS DISEASES
- A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface
- (2019) Sandhya Bangaru et al. CELL
- Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism
- (2019) Akiko Watanabe et al. CELL
- Development of Influenza B Universal Vaccine Candidates Using the “Mosaic” Hemagglutinin Approach
- (2019) Weina Sun et al. JOURNAL OF VIROLOGY
- mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
- (2019) Robert A. Feldman et al. VACCINE
- A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains
- (2019) Felix Broecker et al. npj Vaccines
- Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine
- (2019) Kenta Matsuda et al. Science Immunology
- Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial
- (2019) Cristina Carter et al. PLoS One
- Broadly protective human antibodies that target the active site of influenza virus neuraminidase
- (2019) Daniel Stadlbauer et al. SCIENCE
- Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
- (2019) David I Bernstein et al. LANCET INFECTIOUS DISEASES
- Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis
- (2018) Jason K. H. Lee et al. Expert Review of Vaccines
- HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
- (2018) Peter D. Kwong et al. IMMUNITY
- A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases
- (2018) Emily J Erbelding et al. JOURNAL OF INFECTIOUS DISEASES
- Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara–Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial
- (2018) Rory D de Vries et al. JOURNAL OF INFECTIOUS DISEASES
- Generation of a broadly reactive influenza H1 antigen using a consensus HA sequence
- (2018) Xianqiang Ping et al. VACCINE
- Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus
- (2018) Jae-Keun Park et al. mBio
- A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA
- (2018) Sandhya Bangaru et al. Nature Communications
- Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera
- (2018) Hadi M. Yassine et al. Scientific Reports
- Immune responses after live attenuated influenza vaccination
- (2018) Kristin G.-I. Mohn et al. Human Vaccines & Immunotherapeutics
- Adjuvanted influenza vaccines
- (2018) John S. Tregoning et al. Human Vaccines & Immunotherapeutics
- H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation
- (2018) James D. Allen et al. Human Vaccines & Immunotherapeutics
- Cell culture-derived flu vaccine: Present and future
- (2018) Alberto Pérez Rubio et al. Human Vaccines & Immunotherapeutics
- Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture
- (2018) Daniela S. Rajão et al. Frontiers in Microbiology
- Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
- (2018) L. Coughlan et al. EBioMedicine
- Using the Influenza Patient-reported Outcome (FLU-PRO) diary to evaluate symptoms of influenza viral infection in a healthy human challenge model
- (2018) Alison Han et al. BMC INFECTIOUS DISEASES
- A Synthetic Micro-Consensus DNA Vaccine Generates Comprehensive Influenza A H3N2 Immunity and Protects Mice Against Lethal Challenge by Multiple H3N2 Viruses
- (2018) Sarah T.C. Elliott et al. HUMAN GENE THERAPY
- Development of a Pan-H1 Influenza Vaccine
- (2018) Nicole Darricarrère et al. JOURNAL OF VIROLOGY
- Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
- (2018) Norbert Pardi et al. Nature Communications
- Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus
- (2018) Kaitlyn M. Morabito et al. Frontiers in Immunology
- Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections
- (2018) Valentina Bernasconi et al. Frontiers in Immunology
- AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
- (2018) Surender Khurana et al. npj Vaccines
- DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial
- (2018) Katherine V. Houser et al. PLoS One
- Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs
- (2018) E. R. Job et al. npj Vaccines
- The way forward: Potentiating protective immunity to novel and pandemic influenza through engagement of memory CD4 T cells
- (2018) Andrea J Sant JOURNAL OF INFECTIOUS DISEASES
- Influenza Vaccines: Good, But We Can Do Better
- (2018) Catharine I Paules et al. JOURNAL OF INFECTIOUS DISEASES
- Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain
- (2018) Florian Krammer et al. JOURNAL OF INFECTIOUS DISEASES
- The Pathway to a Universal Influenza Vaccine
- (2017) Catharine I. Paules et al. IMMUNITY
- A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus
- (2017) Nicholas C. Wu et al. JOURNAL OF MOLECULAR BIOLOGY
- Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants
- (2017) Terianne M. Wong et al. JOURNAL OF VIROLOGY
- Development of an Alternative Modified Live Influenza B Virus Vaccine
- (2017) Jefferson J. S. Santos et al. JOURNAL OF VIROLOGY
- Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine
- (2017) Eva van Doorn et al. MEDICINE
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older
- (2017) Lisa M. Dunkle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody
- (2017) Donald D. Raymond et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy
- (2017) Srinivasa Reddy Bonam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Back to the future: Immunization with M-001 prior to trivalent influenza vaccine in 2011/12 enhanced protective immune responses against 2014/15 epidemic strain
- (2017) George H. Lowell et al. VACCINE
- Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis
- (2017) Krista Wilkinson et al. VACCINE
- M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza
- (2017) Yasuko Hatta et al. VACCINE
- Basic principles of test-negative design in evaluating influenza vaccine effectiveness
- (2017) Wakaba Fukushima et al. VACCINE
- A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus
- (2017) Shin-Hee Kim et al. VIROLOGY
- Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin
- (2017) Madhusudan Rajendran et al. mBio
- Is It Possible to Develop a “Universal” Influenza Virus Vaccine?
- (2017) Sarah F. Andrews et al. Cold Spring Harbor Perspectives in Biology
- Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design
- (2017) Sinthujan Jegaskanda et al. Human Vaccines & Immunotherapeutics
- An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial
- (2017) Adam D. DeZure et al. npj Vaccines
- A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques
- (2017) Nicholas W. Florek et al. PLoS One
- A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
- (2017) Neal Van Hoeven et al. Scientific Reports
- Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production
- (2016) Felipe Tapia et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses
- (2016) M. Gordon Joyce et al. CELL
- Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
- (2016) Nicole L. Kallewaard et al. CELL
- A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults
- (2016) Stéphane Pillet et al. CLINICAL IMMUNOLOGY
- M2-based influenza vaccines: recent advances and clinical potential
- (2016) Annasaheb Kolpe et al. Expert Review of Vaccines
- Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses
- (2016) Donald M. Carter et al. JOURNAL OF VIROLOGY
- Replicating Single-Cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses
- (2016) Catherine M. Crosby et al. JOURNAL OF VIROLOGY
- Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain
- (2016) Donald D Raymond et al. NATURE MEDICINE
- High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses
- (2016) Jin Hyang Kim et al. VACCINE
- The 2015 global production capacity of seasonal and pandemic influenza vaccine
- (2016) Kenneth A. McLean et al. VACCINE
- Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines
- (2016) Jennifer Mullin et al. VACCINE
- M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice
- (2016) Sally Sarawar et al. VACCINE
- Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine
- (2016) Mariette F. Ducatez et al. VETERINARY MICROBIOLOGY
- Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model
- (2016) Matthew J. Memoli et al. mBio
- A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve
- (2016) Ying Fu et al. Nature Communications
- Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine
- (2016) Nuriban Valero-Pacheco et al. PLoS One
- Prospects for Broadly Protective Influenza Vaccines
- (2015) John Jay Treanor AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Viral Receptor-Binding Site Antibodies with Diverse Germline Origins
- (2015) Aaron G. Schmidt et al. CELL
- Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost
- (2015) Julie E. Ledgerwood et al. Contemporary Clinical Trials
- Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
- (2015) Nikolai Petrovsky DRUG SAFETY
- Current and next generation influenza vaccines: Formulation and production strategies
- (2015) Peter C. Soema et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection
- (2015) Arnold S. Monto et al. JOURNAL OF INFECTIOUS DISEASES
- Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses
- (2015) Qinfang Liu et al. JOURNAL OF VIROLOGY
- Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice
- (2015) Teddy John Wohlbold et al. JOURNAL OF VIROLOGY
- High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial
- (2015) David Liebowitz et al. LANCET INFECTIOUS DISEASES
- Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis
- (2015) Hector S Izurieta et al. LANCET INFECTIOUS DISEASES
- Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
- (2015) Hadi M Yassine et al. NATURE MEDICINE
- Advances in the development of influenza virus vaccines
- (2015) Florian Krammer et al. NATURE REVIEWS DRUG DISCOVERY
- Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults
- (2015) Michelle C. Crank et al. PLoS One
- DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial
- (2015) Julie E. Ledgerwood et al. PLoS One
- A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
- (2015) A. Impagliazzo et al. SCIENCE
- Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets
- (2015) Ye V. Liu et al. VACCINE
- Virus-specific T cells as correlate of (cross-)protective immunity against influenza
- (2015) Arwen F. Altenburg et al. VACCINE
- Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
- (2015) Teddy John Wohlbold et al. mBio
- A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus
- (2015) Ying Wu et al. Nature Communications
- Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review
- (2015) Barbara Camilloni et al. Human Vaccines & Immunotherapeutics
- Characterization of Drug-Resistant Influenza Virus A(H1N1) and A(H3N2) Variants SelectedIn Vitrowith Laninamivir
- (2014) Mélanie Samson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in Humans
- (2014) Florian Krammer et al. Clinical and Vaccine Immunology
- Dramatic Decline of Respiratory Illness Among US Military Recruits After the Renewed Use of Adenovirus Vaccines
- (2014) J. M. Radin et al. CLINICAL INFECTIOUS DISEASES
- Validation of the Wild-type Influenza A Human Challenge Model H1N1pdMIST: An A(H1N1)pdm09 Dose-Finding Investigational New Drug Study
- (2014) Matthew J. Memoli et al. CLINICAL INFECTIOUS DISEASES
- Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ
- (2014) Anthony L. Desbien et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Efficacy and Safety of Treatment With an Anti-M2e Monoclonal Antibody in Experimental Human Influenza
- (2014) Eleanor L. Ramos et al. JOURNAL OF INFECTIOUS DISEASES
- Broad Protection against Avian Influenza Virus by Using a Modified Vaccinia Ankara Virus Expressing a Mosaic Hemagglutinin Gene
- (2014) A. Kamlangdee et al. JOURNAL OF VIROLOGY
- Modified Vaccinia Virus Ankara Encoding Influenza Virus Hemagglutinin Induces Heterosubtypic Immunity in Macaques
- (2014) N. W. Florek et al. JOURNAL OF VIROLOGY
- Flow Cytometry Reveals that H5N1 Vaccination Elicits Cross-Reactive Stem-Directed Antibodies from Multiple Ig Heavy-Chain Lineages
- (2014) J. R. R. Whittle et al. JOURNAL OF VIROLOGY
- Induction of Broadly Reactive Anti-Hemagglutinin Stalk Antibodies by an H5N1 Vaccine in Humans
- (2014) R. Nachbagauer et al. JOURNAL OF VIROLOGY
- Characterization of a Broadly Neutralizing Monoclonal Antibody That Targets the Fusion Domain of Group 2 Influenza A Virus Hemagglutinin
- (2014) G. S. Tan et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
- (2014) Joost H C M Kreijtz et al. LANCET INFECTIOUS DISEASES
- Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
- (2014) Carlos A. DiazGranados et al. NEW ENGLAND JOURNAL OF MEDICINE
- MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses
- (2014) Annett Hessel et al. PLoS One
- GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza
- (2014) Christopher H. Clegg et al. PLoS One
- Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans
- (2014) A. H. Ellebedy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Priming by a novel universal influenza vaccine (Multimeric-001)—A gateway for improving immune response in the elderly population
- (2014) Jacob Atsmon et al. VACCINE
- Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers
- (2014) Jenny G.H. Low et al. VACCINE
- Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus
- (2014) Peter S. Lee et al. Nature Communications
- Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulating A(H3N2) strains
- (2014) Barbara Camilloni et al. Immunity & Ageing
- An In Vivo Human-Plasmablast Enrichment Technique Allows Rapid Identification of Therapeutic Influenza A Antibodies
- (2013) Gerald Nakamura et al. Cell Host & Microbe
- Traditional and New Influenza Vaccines
- (2013) S.-S. Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine
- (2013) Caitlin E. Mullarkey et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect
- (2013) Julie E. Ledgerwood, Kathryn Zephir, Zonghui Hu, Chih-Jen Wei, LeeJah Chang, Mary E. Enama, Cynthia S. Hendel, Sandra Sitar, Robert T. Bailer, Richard A. Koup, John R. Mascola, Gary J. Nabel, Barney S. Graham et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody Correlates and Predictors of Immunity to Naturally Occurring Influenza in Humans and the Importance of Antibody to the Neuraminidase
- (2013) Robert B. Couch et al. JOURNAL OF INFECTIOUS DISEASES
- Molecular Basis for Broad Neuraminidase Immunity: Conserved Epitopes in Seasonal and Pandemic H1N1 as Well as H5N1 Influenza Viruses
- (2013) H. Wan et al. JOURNAL OF VIROLOGY
- Antibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site
- (2013) M. Hong et al. JOURNAL OF VIROLOGY
- H3 Stalk-Based Chimeric Hemagglutinin Influenza Virus Constructs Protect Mice from H7N9 Challenge
- (2013) F. Krammer et al. JOURNAL OF VIROLOGY
- Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin
- (2013) C. Dreyfus et al. JOURNAL OF VIROLOGY
- Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses
- (2013) I. Margine et al. JOURNAL OF VIROLOGY
- Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
- (2013) F. Krammer et al. JOURNAL OF VIROLOGY
- AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial
- (2013) Janet E McElhaney et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study
- (2013) Marc Gurwith et al. LANCET INFECTIOUS DISEASES
- Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
- (2013) Richard D Antrobus et al. MOLECULAR THERAPY
- Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses
- (2013) Richard D Antrobus et al. MOLECULAR THERAPY
- Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
- (2013) Masaru Kanekiyo et al. NATURE
- Cellular immune correlates of protection against symptomatic pandemic influenza
- (2013) Saranya Sridhar et al. NATURE MEDICINE
- A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin
- (2013) Rui Xu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine
- (2013) Louis F. Fries et al. NEW ENGLAND JOURNAL OF MEDICINE
- A common solution to group 2 influenza virus neutralization
- (2013) R. H. E. Friesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glycosylations in the Globular Head of the Hemagglutinin Protein Modulate the Virulence and Antigenic Properties of the H1N1 Influenza Viruses
- (2013) R. A. Medina et al. Science Translational Medicine
- Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans
- (2013) Wendy Peters et al. VACCINE
- Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant
- (2013) John J. Treanor et al. VACCINE
- Haemagglutinin and nucleoprotein replicon particle vaccination of swine protects against the pandemic H1N1 2009 virus
- (2013) R. L. Vander Veen et al. VETERINARY RECORD
- New World Bats Harbor Diverse Influenza A Viruses
- (2013) Suxiang Tong et al. PLoS Pathogens
- Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
- (2012) Patrick J. Lillie et al. CLINICAL INFECTIOUS DISEASES
- Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses
- (2012) J. C. Krause et al. JOURNAL OF VIROLOGY
- Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes
- (2012) R. Hai et al. JOURNAL OF VIROLOGY
- Cross-neutralization of influenza A viruses mediated by a single antibody loop
- (2012) Damian C. Ekiert et al. NATURE
- Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
- (2012) Tom M Wilkinson et al. NATURE MEDICINE
- A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years
- (2012) Richard D. Antrobus et al. PLoS One
- Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody
- (2012) A. G. Schmidt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity
- (2012) P. S. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly Conserved Protective Epitopes on Influenza B Viruses
- (2012) C. Dreyfus et al. SCIENCE
- Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine
- (2012) Ryan L. Vander Veen et al. VACCINE
- Towards a universal vaccine for avian influenza: Protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus
- (2012) Amy C. Boyd et al. VACCINE
- Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti-Influenza A Antibodies
- (2011) J. Sui et al. CLINICAL INFECTIOUS DISEASES
- Influenza viral neuraminidase: the forgotten antigen
- (2011) Bert E Johansson et al. Expert Review of Vaccines
- A Broadly Neutralizing Human Monoclonal Antibody That Recognizes a Conserved, Novel Epitope on the Globular Head of the Influenza H1N1 Virus Hemagglutinin
- (2011) J. C. Krause et al. JOURNAL OF VIROLOGY
- Naturally Occurring Antibodies in Humans Can Neutralize a Variety of Influenza Virus Strains, Including H3, H1, H2, and H5
- (2011) N. Ohshima et al. JOURNAL OF VIROLOGY
- DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
- (2011) Julie E Ledgerwood et al. LANCET INFECTIOUS DISEASES
- Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
- (2011) Michael T Osterholm et al. LANCET INFECTIOUS DISEASES
- Meta-Analysis of the Immunogenicity and Tolerability of Pandemic Influenza A 2009 (H1N1) Vaccines
- (2011) Lamberto Manzoli et al. PLoS One
- A Contributing Role for Anti-Neuraminidase Antibodies on Immunity to Pandemic H1N1 2009 Influenza A Virus
- (2011) Glendie Marcelin et al. PLoS One
- Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin
- (2011) J. R. R. Whittle et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Broadly neutralizing DNA vaccine with specific mutation alters the antigenicity and sugar-binding activities of influenza hemagglutinin
- (2011) Ming-Wei Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
- (2011) D. Corti et al. SCIENCE
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
- (2011) D. C. Ekiert et al. SCIENCE
- A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets
- (2011) Brendan M. Giles et al. VACCINE
- Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI)
- (2011) David N. Taylor et al. VACCINE
- Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults
- (2011) Christine B. Turley et al. VACCINE
- Cross-Reactive T Cells Are Involved in Rapid Clearance of 2009 Pandemic H1N1 Influenza Virus in Nonhuman Primates
- (2011) Jason T. Weinfurter et al. PLoS Pathogens
- Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection
- (2010) K. El Bakkouri et al. JOURNAL OF IMMUNOLOGY
- Molecular Characterization of In Vivo Adjuvant Activity in Ferrets Vaccinated against Influenza Virus
- (2010) Y. Fang et al. JOURNAL OF VIROLOGY
- Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine
- (2010) Gary J Nabel et al. NATURE MEDICINE
- Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
- (2010) C.-J. Wei et al. SCIENCE
- The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response
- (2010) Zhongying Chen et al. VACCINE
- AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice
- (2010) Catherine Caillet et al. VACCINE
- Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins
- (2010) Taia T. Wang et al. PLoS Pathogens
- Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara
- (2009) Guus F Rimmelzwaan et al. Expert Review of Vaccines
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
- (2009) Jianhua Sui et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Antibody Recognition of a Highly Conserved Influenza Virus Epitope
- (2009) D. C. Ekiert et al. SCIENCE
- Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
- (2009) Tino F. Schwarz et al. VACCINE
- Cross-Protective Potential of a Novel Monoclonal Antibody Directed against Antigenic Site B of the Hemagglutinin of Influenza A Viruses
- (2009) Reiko Yoshida et al. PLoS Pathogens
- Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults
- (2008) David I. Bernstein et al. JOURNAL OF INFECTIOUS DISEASES
- Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
- (2008) Mark Throsby et al. PLoS One
- Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies
- (2008) A. K. Kashyap et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started